Skip to main content
Top
Published in: International Journal of Clinical Oncology 5/2009

01-10-2009 | Original Article

Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer

Authors: Kanji Matsuura, Tomoki Kimura, Kozo Kashiwado, Kazushi Fujita, Yukio Akagi, Shintarou Yuki, Yuji Murakami, Koichi Wadasaki, Yoshio Monzen, Atsushi Ito, Masayuki Kagemoto, Masaki Mori, Katsuhide Ito, Yasushi Nagata

Published in: International Journal of Clinical Oncology | Issue 5/2009

Login to get access
Metadata
Title
Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer
Authors
Kanji Matsuura
Tomoki Kimura
Kozo Kashiwado
Kazushi Fujita
Yukio Akagi
Shintarou Yuki
Yuji Murakami
Koichi Wadasaki
Yoshio Monzen
Atsushi Ito
Masayuki Kagemoto
Masaki Mori
Katsuhide Ito
Yasushi Nagata
Publication date
01-10-2009
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 5/2009
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-009-0889-0

Other articles of this Issue 5/2009

International Journal of Clinical Oncology 5/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine